Abstract:Streptococcus pneumoniae colonizes the human nasopharynx and causes several diseases. Pneumococcal vaccines target the polysaccharide capsule and prevent most serious disease, but there has been an increase in the prevalence of nonencapsulated S. pneumoniae (NESp). Previously, it was thought that a capsule was necessary to cause invasive disease. NESp strains expressing the oligopeptide transporters AliC and AliD have been isolated from patients with invasive disease. The AliC and AliD oligopeptide transporters regulate the expression of several genes, including choline binding protein AC (CbpAC) (a homolog of PspA), which aids in reducing C3b deposition. It is hypothesized that by altering CbpAC expression, AliC and AliD provide protection from classical complement-mediated clearance by reducing C-reactive protein (CRP) binding. Our study demonstrates that AliC and AliD regulate CbpAC expression in NESp and that AliD found in certain serotypes of encapsulated strains regulates PspA expression. C3b deposition was increased in the NESp ΔaliD and encapsulated mutants in comparison to the wild type. NESp strains expressing AliC and AliD have a significant decrease in C1q and CRP deposition in comparison to the ΔaliC ΔaliD mutant. The complement protein C1q is required for NESp clearance in a murine model and increases opsonophagocytosis. By regulating CbpAC expression, NESp inhibits CRP binding to the bacterial surface and blocks classical complement activation, leading to greater systemic survival and virulence. Due to the increase in the prevalence of NESp, it is important to gain a better understanding of NESp virulence mechanisms that aid in establishing disease and persistence within a host by avoiding clearance by the immune system. IMPORTANCE Streptococcus pneumoniae (pneumococcus) can cause a range of diseases. Although there is a robust pneumococcal vaccination program that reduces invasive pneumococcal disease by targeting various polysaccharide capsules, there has been an increase in the isolation of nonvaccine serotypes and nonencapsulated S. pneumoniae (NESp) strains. While most studies of pneumococcal pathogenesis have focused on encapsulated strains, there is little understanding of how NESp causes disease. NESp lacks a protective capsule but contains novel genes, such as aliC and aliD, which have been shown to regulate the expression of numerous genes and to be required for NESp virulence and immune evasion. Furthermore, NESp strains have high transformation efficiencies and harbor resistance to multiple drugs. This could be deleterious to current treatment strategies employed for pneumococcal disease as NESp can be a reservoir of drug resistance genes. Therefore, deciphering how NESp survives within a host and facilitates disease is a necessity that will allow the fabrication of improved, broad-spectrum treatments and preventatives against pneumococcal disease. Our study provides a better understanding of NESp virulence mechanisms during host-pathogen interactions through the examination of genes directly regulated by the NESp proteins AliC and AliD.

LPS O Antigen Plays a Key Role in Klebsiella pneumoniae Capsule Retention

Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance

Peptidoglycan Association of Murein Lipoprotein is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia Coli Isolate

Attachment of capsular polysaccharide to the cell wall in Streptococcus pneumoniae

Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization

KEY INFLAMMATORY SIGNALING PATHWAYS ARE REGULATED BY THE PROTEASOME

Synergy between Group 2 capsules and lipopolysaccharide underpins serum resistance in Extra-intestinal Pathogenic Escherichia coli

Conserved Glycolipid Termini in Capsular Polysaccharides Synthesized by ATP-binding Cassette Transporter-Dependent Pathways in Gram-negative Pathogens.

Infection characteristics among capsule lineages.

Capsule type defines the capability of Klebsiella pneumoniae in evading Kupffer cell capture in the liver

<i>O</i>-Acetylation of Capsular Polysialic Acid Enables <i>Escherichia coli</i> K1 Escaping from Siglec-Mediated Innate Immunity and Lysosomal Degradation of <i>E. coli</i>-Containing Vacuoles in Macrophage-Like Cells

Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes

Klebsiella pneumoniae capsular polysaccharide: Mechanism in regulation of synthesis, virulence, and pathogenicity

Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by ABC transporter-dependent pathways

Pushing the envelope: LPS modifications and their consequences

SPD_1495 Contributes to Capsular Polysaccharide Synthesis and Virulence in Streptococcus Pneumoniae

Transition transferases prime bacterial capsule polymerization

Structure of the essential inner membrane lipopolysaccharide-PbgA complex

The bacterial tyrosine kinase system CpsBCD governs the length of capsule polymers

The polysaccharide capsule of affects bacterial adhesion and natural transformation

The unique Legionella longbeachae capsule favors intracellular replication and immune evasion